1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Outcome and complications in 56 patients after carotid occlusion with coils for large, giant, or fusiform aneurysms of the carotid siphon
Characteristics Early FU (≤30 days) (n = 56) Late FU (>30 days) (n = 43) Death (No.) (%) 0 0 Intracranial hemorrhage (No.) (%) 0 0 Ischemic event Resolved symptoms (No.) (%) 10 (18) 4 (9) Minor persistent symptomsa (No.) (%) 2 (3.5) 0 Major persistent symptomsb (No.) (%) 3 (5.5) 0 Pain Resolved or improved (No.) (%) NA 42 (98) Unchanged (No.) (%) NA 0 Worsened (No.) (%) NA 1 (2) Cranial nerve palsy Resolved or improved (No.) (%) NA 23c (72) Unchanged (No.) (%) NA 9c (28) Worsened (No.) (%) NA 0 Embolized aneurysm Retracted (No.) (%) NA 39 (91) Unchanged (No.) (%) NA 4 (9) Grown (No.) (%) NA 0 De novo/additional growing aneurysm (No.) (%) NA 1 (2)